We also reported the overexpression of MYC and BCL2 in DLBCL cases were possiblely associated with CISD2Risk value, and the double-expressor DLBCL exhibited the high CISD2Risk value (P < 0.05, Figure 5L). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.